Relationship between the hs-CRP as non-specific biomarker and Alzheimer’s disease according to aging process

International Journal of Medical Sciences

Volumn 12, Issue 8, 2015, Pages 613-617

  Song, In Uk ^a   Chung, Sung Woo ^a   Kim, Young Do ^a   Maeng, Lee So ^a  

^a Bupyeong gu   (South Korea)

Author keywords

Aging process; Alzheimer s disease; High sensitivity C reactive protein; Microglia

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENESCENCE; VERY ELDERLY; BLOOD; BRAIN; CASE CONTROL STUDY; DEGENERATIVE DISEASE; INFLAMMATION; METABOLISM; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BIOMARKERS; BRAIN; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MICROGLIA; NEURODEGENERATIVE DISEASES; NEURONS; PROSPECTIVE STUDIES;

EID: 84938538727     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.12742     Document Type: Article

References (17)

1. Song IU, Kim JS, Chung SW, et al. Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals. Eur Neurol. 2009 62: 99-104.
2. Windgassen EB, Funtowicz L, Lunsford TN, et al. C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med. 2011 123: 114-9.
3. Hsuchou H, Kastin AJ, Mishra PK, et al. C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation. Cell Physiol Biochem. 2012 30: 1109-19.
4. Song IU, Kim YD, Cho HJ, et al. Is neuroinflammation involved in the development of dementia in patients with Parkinson's disease? Intern Med. 2013 52: 1787-92.
5. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996 19: 312-8.
6. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000 31: 578-85.
7. Ginaldi L, De Martinis M, D'Ostilio A, et al. Immunological changes in the elderly. Aging (Milano). 1999 11: 281-6.
8. Sawada M, Imamura K, Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm Suppl. 2006: 373-81.
9. Sawada M, Sawada H, Nagatsu T. Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases. Neurodegener Dis. 2008 5: 254-6.
10. Luo XG, Ding JQ, Chen SD. Microglia in the aging brain: relevance to neurodegeneration. Mol Neurodegener. 2010 5: 12.
11. Ye SM, Johnson RW. An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation. 2001 9: 183-92.
12. Ogura K, Ogawa M, Yoshida M. Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. Neuroreport. 1994 5: 1224-6.
13. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 34: 939-44.
14. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993 43: 250-60.
15. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005 76: 77-98.
16. Kumagai N, Chiba Y, Hosono M, et al. Involvement of pro-inflammatory cytokines and microglia in an age-associated neurodegeneration model, the SAMP10 mouse. Brain Res. 2007 1185: 75-85.
17. McGeer PL, McGeer EG, Yasojima K. Alzheimer disease and neuroinflammation. J Neural Transm Suppl. 2000 59: 53-7.